Sellas Life Sciences
SLS
$1.35
Share price
5.47%
Change (1 day)
-8.16%
Change (1 year)
Categories
Sellas Life Sciences (SLS) - Cash on Hand
Cash on Hand as of December 2023 : $2.53 M
According to Sellas Life Sciences's latest financial reports the company has $2.53 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Sellas Life Sciences - Cash on Hand chart (from 2006 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $17.12 M | -19.81% |
| 2021-12-31 | $21.35 M | -39.51% |
| 2020-12-31 | $35.3 M | 385.12% |
| 2019-12-31 | $7.27 M | 36.35% |
| 2018-12-31 | $5.33 M | 130.14% |
| 2017-12-31 | $2.31 M | -61.1% |
| 2016-12-31 | $5.96 M | -79.95% |
| 2015-12-31 | $29.73 M | 25.71% |
| 2014-12-31 | $23.65 M | -50.51% |
| 2013-12-31 | $47.78 M | 34.67% |
| 2012-12-31 | $35.48 M | 210.37% |
| 2011-12-31 | $11.43 M | 65.91% |
| 2010-12-31 | $6.89 M | 21.24% |
| 2009-12-31 | $5.68 M | -42.33% |
| 2008-12-31 | $9.85 M | -15.87% |
| 2007-12-31 | $11.71 M | 585650% |
| 2006-12-31 | $0 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 8,128.74% | 🇺🇸 USA |